Accordingly, administration of VEGF inhibitors as part of antineoplastic chemotherapy has been associated with the development of reversible hypertension and proteinuria [7], [10], [16] and/or glomerular microthrombosis [23], [24]. Here, VEGFA is linked to Hypertension.